The largest U.S. drug distributor, like several of its competitors, remains under fire for its alleged role in America’s destructive opioid epidemic, as plaintiffs and prosecutors accuse it of hiding flaws in its supply chain that made it too easy for doctors to overprescribe and patients to abuse the drugs. In part as a result of a recent settlement with several states, McKesson reported a $4.5 billion loss for the fiscal year ended March 2021. After taking charge as a CDC-appointed centralized distributor for COVID vaccines in the U.S., McKesson had distributed about 246 million doses as of December 2021. McKesson’s oncology tech business, Ontada, joined MYLUNG to advance precision medicine for lung cancer patients.
Courtesy of McKesson
Company Information
As of 2/1/2023
Country
U.S.
Headquarters
Irving, Texas
Industry
Wholesalers: Health Care
CEO
Brian S. Tyler
Website
Company Type
Public
Ticker
MCK
Revenues ($M)
$272,027
Profits ($M)
$2,055
Market Value ($M)
$53,604
Employees
66,500
Figures are for the latest twelve months ended Sept. 30, 2022. Market value as of Jan. 20, 2023. Sources: Bloomberg; S&P Global.
Key Financials (Last Fiscal Year)As of 8/3/2022
($ Millions)
% change
Revenues ($M)
$263,966
10.8%
Profits ($M)
$1,114
-
Assets ($M)
$63,298
-
Total Stockholder Equity ($M)
$-2,272
-
Profit RatiosAs of 8/3/2022
Profit as % of Revenues
0.4%
Profits as % of Assets
1.8%
Profits as % of Stockholder Equity
-
McKesson Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $238,2283.1% | $-4,539-604.3% | $65,015 | $-21 |
| 2020 | $231,0517.8% | $9002547.1% | $61,247 | $5,092 |
| 2019 | $214,3192.9% | $34-49.3% | $59,672 | $8,094 |
| 2018 | $208,3574.9% | $67-98.7% | $60,381 | $9,804 |
| 2017 | $198,5333.1% | $5,070124.5% | $60,969 | $11,095 |
SHOW MORE
Lists ranking McKesson
Latest news for McKesson
- Success
How the top 10 Fortune 500 companies are bringing workers back to the officeAugust 14, 2022, 1:00 PM UTC - Health
Johnson & Johnson, drug distributors reach $26 billion settlement with states over opioidsJuly 21, 2021, 7:25 PM UTC - Health
4 Drug Giants Reach $260 Million Settlement in Ohio Opioid Case. What Happens Next?October 21, 2019, 5:27 PM UTC
